Exploring a New Natural Treating Agent for Primary Hypertension: Recent Findings and Forthcoming Perspectives.

Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 97401, Taiwan. Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei 110, Taiwan. Department of Anatomy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Camillian Saint Mary's Hospital Luodong,160 Zhongzheng S. Rd. Luodong, Yilan 26546, Taiwan. Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Department of Basic Medical Science, Center for Transitional Medicine, Xiamen Medical College, Xiamen 361023, China.

Journal of clinical medicine. 2019;(11)
Full text from:

Other resources

Abstract

Primary hypertension describes abnormally-high systolic/diastolic blood pressure in a resting condition caused by various genetic or environmental risk factors. Remarkably, severe complications, such as ischemic cardiovascular disease, stroke, and chronic renal disease have led to primary hypertension becoming a huge burden for almost one-third of the total population. Medication is the major regimen for treating primary hypertension; however, recent medications may have adverse effects that attenuate energy levels. Hence, the search for new hypotensive agents from folk or traditional medicine may be fruitful in the discovery and development of new drugs. This review assembles recent findings for natural antihypertensive agents, extracts, or decoctions published in PubMed, and provides insights into the search for new hypotensive compounds based on blood-pressure regulating mechanisms, including the renin-angiotensin-aldosterone system and the sympathetic/adrenergic receptor/calcium channel system.

Methodological quality

Publication Type : Review

Metadata